Genotyping of clinical isolates of Candida glabrata from Iran by multilocus sequence typing and determination of population structure and drug resistance profile

MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata

(2015) C. Dhieb et al.   MEDICAL MYCOLOGY

Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options

(2012) J. C. O. Sardi et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Bloodstream and non-invasive isolates ofCandida glabratahave similar population structures and fluconazole susceptibilities

(2012) Timothy J. Lott et al.   MEDICAL MYCOLOGY

Candidemia Surveillance in Brazil: Evidence for a Geographical Boundary Defining an Area Exhibiting an Abatement of Infections by Candida albicans Group 2 Strains

(2010) D. A. Da Matta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multilocus Microsatellite Markers for Molecular Typing of Candida glabrata: Application to Analysis of Genetic Relationships between Bloodstream and Digestive System Isolates

(2010) A. Enache-Angoulvant et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Microsatellite analysis and susceptibility to FCZ ofCandida glabratainvasive isolates in Sfax Hospital, Tunisia

(2010) S. Abbes et al.   MEDICAL MYCOLOGY

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

(2009) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Multilocus Sequence Typing of PathogenicCandidaSpecies

(2008) Frank C. Odds et al.   EUKARYOTIC CELL